Fzd7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[@grigoryan2021]
[@jiang2020]
| Symbol | FZD7 |
| Full Name | Frizzled Class Receptor 7 |
| Chromosome | 2q33.3 |
| NCBI Gene ID | 8324 |
| Ensembl ID | ENSG00000155729 |
| OMIM ID | 603410 |
| UniProt ID | O75084 |
| Associated Diseases | Alzheimer's Disease, Cancer, Autism Spectrum Disorder |
FZD7 (Frizzled Class Receptor 7) is a seven-transmembrane receptor that primarily activates canonical Wnt/β-catenin signaling. It plays critical roles in embryonic stem cell maintenance, neural progenitor proliferation, and tissue morphogenesis. FZD7 is highly expressed in neural stem cells and progenitor populations.
FZD7 (Frizzled Class Receptor 7) is a seven-transmembrane receptor belonging to the Frizzled family of Wnt receptors. It functions as the primary receptor for canonical Wnt/β-catenin signaling and plays critical roles in embryonic stem cell maintenance, neural progenitor proliferation, and tissue morphogenesis.
FZD7 is a major Wnt receptor for the β-catenin pathway[@wntneuro2023]:
- High affinity ligands: Binds Wnt1, Wnt2, Wnt3, and Wnt3A with high specificity
- Stem cell pluripotency: Maintains embryonic stem cell self-renewal through β-catenin stabilization
- Progenitor proliferation: Promotes expansion of neural progenitor cells during development
- Cell fate decisions: Regulates differentiation into neuronal and glial lineages
The canonical Wnt/FZD7 signaling cascade involves:
- Wnt ligand binding to FZD7 extracellular domain
- Recruitment of LRP5/LRP6 co-receptors
- Dishevelled (DVL) protein phosphorylation
- β-catenin stabilization and nuclear translocation
- TCF/LEF-mediated gene transcription
Beyond canonical signaling, FZD7 also participates in non-canonical pathways:
- Planar cell polarity (PCP): Regulates cell polarity and tissue morphogenesis
- Wnt/Ca²⁺ pathway: Modulates calcium signaling and neuronal activity
- RhoA/ROCK signaling: Controls cytoskeletal dynamics and cell migration
FZD7 is essential for neural stem cell biology[@kalani2022]:
- Maintains neural stem cell population in the ventricular zone
- Controls progenitor proliferation during neurogenesis
- Regulates neurogenesis by promoting neuronal differentiation
- Modulates gliogenesis in later developmental stages
- Essential for hippocampal neural stem cell function in adults
In mature neurons, FZD7 plays crucial roles in synaptic function[@fzd7synapse2020]:
- Modulates synapse formation and maintenance
- Regulates dendritic spine density and morphology
- Controls AMPA receptor trafficking to synapses
- Mediates long-term potentiation (LTP) and memory consolidation
- Influences NMDA receptor function and calcium signaling
The Wnt/FZD7 pathway intersects with neuroinflammatory processes[@wntneuro2022]:
- Regulates microglial activation and cytokine production
- Modulates astrocyte reactivity in neurodegeneration
- Controls peripheral immune cell infiltration
- Links neuroinflammation to cognitive decline in AD
FZD7 is critically involved in AD pathogenesis through multiple mechanisms[@fzd7ad2021][@wntneuro2023]:
- Wnt signaling dysregulation: Reduced Wnt/β-catenin signaling in AD brains contributes to neuronal loss
- Neural stem cell impairment: FZD7-mediated neural progenitor proliferation declines with age and AD
- Amyloid-β interaction: Amyloid-β oligomers disrupt FZD7 signaling and synaptic function
- Tau pathology: FZD7 dysfunction exacerbates tau hyperphosphorylation and NFT formation
- Memory decline: Age-associated FZD7 downregulation correlates with memory deficits[@fzd7memory2021]
- Therapeutic potential: FZD7 activation represents a novel therapeutic strategy for AD
FZD7 in PD:
- Dopaminergic neuron survival requires intact Wnt/FZD7 signaling
- FZD7 expression is altered in PD substantia nigra
- Interaction with LRRK2 (Leucine-Rich Repeat Kinase 2) pathogenic mutations
FZD7 is frequently overexpressed in multiple cancers:
- Colorectal cancer: Oncogenic driver, promotes Wnt-dependent tumor growth
- Breast cancer: Associated with triple-negative breast cancer subtypes
- Hepatocellular carcinoma: Promotes cell proliferation and metastasis
- Gliomas: Contributes to tumor stem cell maintenance
FZD7 associations[@fzd7autism2018]:
- Rare de novo variants identified in ASD patients
- Altered synaptic development and connectivity
- Potential for targeted therapeutic intervention
- FZD7 mutations can cause forebrain developmental abnormalities
- Essential for cortical layering and circuit formation
FZD7 exhibits specific expression patterns in the nervous system:
- Neural stem cells: High expression in the ventricular zone during development
- Embryonic brain: Strong expression in cerebral cortex, hippocampus, and basal ganglia
- Adult brain: Maintained in the subventricular zone (SVZ) and hippocampal dentate gyrus
- Cerebral cortex: Layer-specific expression in cortical neurons
- Cerebellum: Expressed in Purkinje cells and granule cell precursors
- Peripheral nervous system: Sensory neurons and neural crest derivatives
- FZD7 in neural stem cells and neurodegeneration - Stem Cell Reports (2022) - DOI:10.1016/j.stemcr.2022.02.015
- Wnt/Fzd7 in embryonic stem cell maintenance - Cell Stem Cell (2021) - DOI:10.1016/j.stem.2021.03.012
- Frizzled-7 in cancer progression - Nature Reviews Cancer (2020) - DOI:10.1038/s41568-020-0245-2
FZD7 interacts with:
- WNT1, WNT2, WNT3, WNT3A: Wnt ligands
- LRP5, LRP6: Co-receptors
- DVL1, DVL2, DVL3: Dishevelled proteins
- RSPO1-3: R-spondins
FZD7-based approaches:
- FZD7 antagonists for cancer
- Wnt pathway modulators for neurodegeneration
- Stem cell therapy enhancement
The study of Fzd7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kalani MY, et al, "Frizzled-7 in neural stem cell biology." Stem Cell Reports (2022)
- Grigoryan T, et al, "Wnt signaling and embryonic stem cell maintenance." Cell Stem Cell (2021)
- Jiang WG, et al, "FZD7 in cancer: new insights." Nature Reviews Cancer (2020)
- Zhang Y, et al, "Wnt/β-catenin signaling in neurodegenerative diseases." Molecular Neurobiology (2023)
- Palomer E, et al, "Frizzled-7 is a novel therapeutic target in Alzheimer's disease." Acta Neuropathologica Communications (2021)
- Chen J, et al, "Frizzled-7 regulates synaptic plasticity and cognitive function." Journal of Neuroscience (2020)
- Niehrs C, "Wnt signaling in development and disease." Developmental Biology (2019)
- Du J, et al, "FZD7 mutations associated with autism spectrum disorders." Molecular Autism (2018)
- Marchetti B, et al, "Wnt signaling in neuroinflammation and neurodegeneration." Frontiers in Cellular Neuroscience (2022)
- Liu X, et al, "Frizzled-7 mediates age-associated memory decline." Aging Cell (2021)